Showing results (101-110 of 205) with videos related to
Sort By:
Pageof 21
Statistics in Medicine|July 15, 1994
The what, why and how of Bayesian clinical trials monitoringL S Freedman, D J Spiegelhalter, M K ParmarPharmacology, Biochemistry, and Behavior|October 1, 1978
Brain and adrenal tyrosine hydroxylase activity after chronic footshock stressE A Stone, L S Freedman, L E MorganoBiometrics|March 1, 1992
The impact of stopping rules on heterogeneity of results in overviews of clinical trialsM D Hughes, L S Freedman, S J PocockInjury|January 1, 1988
Carbon fibre reinforcement for chronic lateral ankle instabilityL S Freedman, A I Jenkins, D H JenkinsControlled Clinical Trials|March 1, 1986
Monitoring clinical trials: conditional or predictive power?D J Spiegelhalter, L S Freedman, P R BlackburnStatistics in Medicine|July 15, 1994
The CHART trials: Bayesian design and monitoring in practice. CHART Steering CommitteeM K Parmar, D J Spiegelhalter, L S FreedmanStatistics in Medicine|August 1, 1993
Applying Bayesian ideas in drug development and clinical trialsD J Spiegelhalter, L S Freedman, M K ParmarJournal of Cellular Biochemistry. Supplement|January 1, 1993
Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive drug actionC W Boone, G J Kelloff, L S FreedmanBiometrics|December 1, 1991
Using replicate observations in observer agreement studies with binary assessmentsS G Baker, L S Freedman, M K ParmarStatistics in Medicine|January 30, 1993
The design of observer agreement studies with binary assessmentsL S Freedman, M K Parmar, S G BakerPageof 21